Jacqueline Cloos

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.

K. Döhner, M. Heuser, C. Hourigan, 2023, American journal of hematology.

Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome.

J. Cloos, D. Cucchi, R. Groen, 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

F. Kavelaars, P. Merle, M. Rijken, 2021 .

Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry

V. V. D. van der Velden, J. te Marvelde, A. Kelder, 2023, Cytometry. Part B, Clinical cytometry.